<i>CRLF2</i> -rearranged B-cell ALL with extramedullary lineage switch to AML following CD19-targeted therapySara Silbert, Nirali N. Shah, Hao‐Wei Wang et al.|Journal for ImmunoTherapy of Cancer|2024Cited by 8